Effects on Blood Pressure and Central Sympathetic Nerve Traffic by SGLT2-inhibition With Empagliflozin Compared to Hydrochlorothiazide in Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 13 Dec 2017
At a glance
- Drugs Empagliflozin (Primary) ; Hydrochlorothiazide
- Indications Hypertension; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 24 Nov 2017 Status changed from not yet recruiting to recruiting.
- 02 Oct 2017 Planned End Date changed from 15 Aug 2019 to 15 Sep 2019.